Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft
2016 · Nature Communications · 461 citations
https://doi.org/10.1038/ncomms11138
P
Philip C. Corcoran
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
2.3K
Citations
23
h-index
34
i10-index
Philip C. Corcoran is an academic researcher. The author has contributed to research in topics: Xenotransplantation and immune response & Transplantation: Methods and Outcomes & Tissue Engineering and Regenerative Medicine. The author has an h-index of 23, co-authored 50 publications.
Papers by this author
worksB-Cell Depletion Extends the Survival of GTKO.hCD46Tg Pig Heart Xenografts in Baboons for up to 8 Months
2011 · American Journal of Transplantation · 156 citations
https://doi.org/10.1111/j.1600-6143.2011.03846.x
One-Year Heterotopic Cardiac Xenograft Survival in a Pig to Baboon Model
2013 · American Journal of Transplantation · 116 citations
https://doi.org/10.1111/ajt.12562
Heterotopic Porcine Cardiac Xenotransplantation in the Intra-Abdominal Position in a Non-Human Primate Model
2020 · Scientific Reports · 22 citations
https://doi.org/10.1038/s41598-020-66430-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat